N@N

The Medicines Company to Participate in the 2010 Citi Global Health Care Conference

_{//health-fitness.news-articles.net/content/2010/ .. the-2010-citi-global-health-care-conference.html}
^{Published in Health and Fitness on Wednesday, May 19th 2010 at 13:40 GMT by Market Wire}  

PARSIPPANY, NJ--(Marketwire - May 19, 2010) - The Medicines Company (NASDAQ: [ MDCO ]) will present at the 2010 Citi Global Health Care Conference on Wednesday , May 26^th, in New York, beginning at 11am Eastern Time. Clive Meanwell, Chairman and Chief Executive Officer, will provide a company overview and outlook in the presentation.

The session will be webcast with a link available at The Medicines Company's website [ http://www.themedicinescompany.com ] under "Events."

About The Medicines Company
The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Medicines Company's website is [ www.themedicinescompany.com ].